13 Dec 2018 08:30
13 December 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
Director and PCA Dealings
Further to the Company's announcements on 26 November 2018 and 12 December 2018, MedaPhor announces that certain Directors, persons closely associated ("PCA") with them and an employee have, following Admission today, acquired a total of 1,847,064 ordinary shares of 1 pence each in the Company ("Ordinary Shares") via the Placing:
Name | Title | Number of Placing Shares subscribed for | Value of Placing Shares subscribed for | Resulting shareholding following subscription | Percentage of enlarged share capital following subscription |
Riccardo Pigliucci | Non-Executive Chairman | 117,648 | £ 10,000.08 | 117,648 | 0.1% |
Stuart Gall | Chief Executive Officer | 588,236 | £ 50,000.06 | 628,236 | 0.4% |
Wilson Jennings | Finance Director | 294,118 | £ 25,000.03 | 294,118 | 0.2% |
Nicholas Sleep | Chief Technology Officer | 176,471 | £ 15,000.04 | 226,471 | 0.1% |
Ian Whittaker | Chief Operating Officer | 117,648 | £ 10,000.08 | 349,982 | 0.2% |
Nick Avis* | Non-Executive Director | 141,177 | £ 12,000.06 | 341,177 | 0.2% |
Andrew Barker | Non-Executive Director | 117,648 | £ 10,000.08 | 317,992 | 0.2% |
* Nick Avis' subscription has been made via his children: Alice Avis, Florence Avis and Harriet Avis who have each subscribed for 47,059 Placing Shares. Alice, Florence and Harriet are considered to be persons closely associated with Nick Avis.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a)
| Name
| 1. Riccardo Pigliucci 2. Stuart Gall 3. Wilson Jennings 4. Nicholas Sleep 5. Ian Whittaker 6. Alice Avis 7. Florence Avis 8. Harriet Avis 9. Andrew Barker | ||||
2 | Reason for the notification | |||||
a)
| Position/status
| 1. Non-Executive Chairman 2. Chief Executive Officer 3. Finance Director 4. Chief Technology Officer 5. Chief Operating Officer 6. Person closely associated with Nick Avis (Non-Executive Director) 7. Person closely associated with Nick Avis (Non-Executive Director) 8. Person closely associated with Nick Avis (Non-Executive Director) 9. Non-Executive Director | ||||
b) | Initial notification /Amendment | Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | MedaPhor Group plc | ||||
b) | LEI | 213800K4ZVWL4ZYQAZ70 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB00BN791Q39 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A - single transaction | ||||
e) | Date of the transaction | 13 December 2018 | ||||
f) | Place of the transaction | London Stock Exchange, XLON | ||||
Enquiries:
MedaPhor Group plc | www.medaphor.com |
Stuart Gall, CEO Wilson Jennings, CFO | Tel: +44 (0)29 2075 6534 |
Cenkos Securities - Nominated Advisor and broker | Tel: +44 (0)20 7397 8900 |
Mark Connelly / Cameron MacRitchie (Corporate Finance) | |
Michael Johnson / Julian Morse (Sales) | |
Walbrook PR | Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com |
Anna Dunphy / Paul McManus | Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893 |
MED.L (MED)